The Clinical Trial of the Anti Hepatitis B Placenta Transfer Factor Injection

NCT02412319 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

288

Enrollment

INDUSTRY

Sponsor class

Conditions

HBeAg Positive Chronic Hepatitis B

Interventions

DRUG: Anti-HBV placenta transfer factor injection
OTHER: Placebo

Sponsor

Shineway Pharmaceutical Co.,Ltd